Treatment Options for Early-Stage HER2-Positive Breast Cancer

home / oncview / treatment-options-for-early-stage-her2-breast-cancer

Virginia Kaklamani, MD, DSc, provides a discussion on the frontline and maintenance therapies available for the management of early-stage HER2+ breast cancer.

EP. 1: Goals of Care for HER2+ Breast Cancer

Virginia Kaklamani, MD, DSc;Matthew Fowler, Associate Editor

February 1st 2022

Virginia Kaklamani, MD, DSc, provides an overview of the goals of care for HER2+ breast cancer.

EP. 2: HER2+ Breast Cancer: Frontline Treatment Options

Virginia Kaklamani, MD, DSc;Matthew Fowler, Associate Editor

February 1st 2022

A review of the currently available frontline treatment options for HER2+ breast cancer.

EP. 3: Clinical Trial Data in HER2+ Breast Cancer

Virginia Kaklamani, MD, DSc;Matthew Fowler, Associate Editor

February 8th 2022

Virginia Kaklamani, MD, DSc, provides an overview of the goals of care for HER2+ breast cancer.

EP. 4: HER2+ Breast Cancer and the Role of Maintenance Therapies

Virginia Kaklamani, MD, DSc;Matthew Fowler, Associate Editor

February 8th 2022

Dr. Virginia Kaklamani discusses the role of maintenance therapies for HER2+ breast cancer.

EP. 5: HER2+ Breast Cancer Clinical Pearls

Virginia Kaklamani, MD, DSc;Matthew Fowler, Associate Editor

February 15th 2022

Advice for community physicians treating HER2+ breast cancer.

Do Not Sell My Personal Information

Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777